An ELISA for putative neutralizing antibodies to hepatitis E virus detects antibodies to genotypes 1, 2, 3, and 4.
about
Molecular Biology and Infection of Hepatitis E VirusT-cell epitope mapping of ORF2 and ORF3 proteins of human hepatitis E virus.Application of truncated immunodominant polypeptide from hepatitis E virus (HEV) ORF2 in an assay to exclude nonspecific binding in detecting anti-HEV immunoglobulin MTransmission, diagnosis, and management of hepatitis E: an updateHepatitis E virus ORF2 protein activates the pro-apoptotic gene CHOP and anti-apoptotic heat shock proteinsMolecular virology of hepatitis E virus.Hepatitis E: a complex and global diseaseA single amino acid substitution changes antigenicity of ORF2-encoded proteins of hepatitis E virusChimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus.Molecular biology and replication of hepatitis E virus.Enhanced humoral response in pregnant mice immunized with liposome encapsulated recombinant neutralizing epitope protein of Hepatitis- E virus.A Proline-Rich Domain in the Genotype 4 Hepatitis E Virus ORF3 C-Terminus Is Crucial for Downstream V105DLP108 Immunoactivity.Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity.Hepatitis E virus seroprevalence in pregnant women in Jiangsu, China, and postpartum evolution during six years.Characterization of hepatitis E-specific cell-mediated immune response using IFN-gamma ELISPOT assay.A high-throughput neutralizing assay for antibodies and sera against hepatitis E virusHepatitis E vaccine.Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994Using improved technology for filter paper-based blood collection to survey wild Sika deer for antibodies to hepatitis E virus.In vitro and in vivo mutational analysis of the 3'-terminal regions of hepatitis e virus genomes and repliconsDesign and production of a multiepitope construct derived from hepatitis E virus capsid protein.Protective role of humoral immune responses during an outbreak of hepatitis E in Egypt.Seroprevalence study in forestry workers from eastern Germany using novel genotype 3- and rat hepatitis E virus-specific immunoglobulin G ELISAs.Heparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infection.Valuable antibody detection method for classifying hepatitis E virus genotypes.Laboratory Diagnosis of HEV Infection.Immunobiology and Host Response to HEV.Hepatitis E virus and hepatitis A virus exposures in an apparently healthy high-risk population in Italy.Effects of mRNA secondary structure on the expression of HEV ORF2 proteins in Escherichia coli.The incidence of hepatitis E virus infection in the general population of the USA.Positive reactions on Western blots do not necessarily indicate the epitopes on antigens are continuous.Generation in yeast and antigenic characterization of hepatitis E virus capsid protein virus-like particles.Serum immunoglobulin G subclass responses in different phases of hepatitis E virus infection.Hepatitis E virus isolated from rabbits is genetically heterogeneous but with very similar antigenicity to human HEV.
P2860
Q28066101-4388465C-2444-44B7-A7FD-C9677CBEEAF5Q33279839-9CC533E4-C756-4408-945F-C341D9E6730CQ33704689-B4A82B14-FBE3-4F6D-9A75-D18A162D8521Q33734018-A8732EA2-6CE5-4DA5-9821-284741ABEC46Q34038276-B59837F2-5B8A-45B7-8978-C9395E30CE7CQ34166393-F3BCEB99-DAC6-4B47-82E5-300F35CE8214Q34264481-5201DB1B-24CE-4FAC-932F-06D1DF074C49Q34377883-B868960A-7D62-4439-8C32-CA6A4D4A1A97Q34478724-01EE6E45-ECDD-4550-8AF2-DF4CF76197B8Q34479052-410B5853-FDA6-4D0D-9BDF-32341FAD67E6Q35683323-7F1165AF-8DC2-49C4-B616-6FAECE166D5EQ35692437-3F7088F2-BF17-463D-99A6-64764F50D019Q35783632-1D4F7F2B-12C7-40CB-9668-1D23C1E4D215Q35865394-7C4AF7AC-776E-48C6-94B2-9B340B377C8BQ36168745-535CE9DC-F98C-4318-A39E-2BFF2954421CQ36845713-A24E14A6-DC0E-445A-B42B-7EFB58EDDA88Q37278231-3D2F889C-9DB8-4C90-98F9-2B3D467E221AQ37389167-F92776CF-A160-4AC0-B5F1-D0F1EB77A6E6Q37405170-7479575B-CF10-40D2-9922-2EF00F946EFEQ37742786-2D822AC6-4884-4147-8898-7740F3121C06Q39027960-B9A4D712-7937-4A42-A578-97443C109D16Q39453500-618D1AFA-D359-4DC5-9775-A113BCE491E7Q39674645-1A3CAF18-4D33-45AF-8451-A1832E134A90Q39790232-2FCD9032-6820-44D2-8AD3-501FE379D560Q40079762-3868B679-D61C-4333-9573-736E3CC85423Q40507410-3B0D6542-6306-459B-BE3B-955913C312B8Q40507436-E28BE305-610B-4D61-AC8D-B93924570DD5Q42281689-82E6BB65-836C-42D3-97DE-BCF32657D0B8Q45029264-4851177A-9853-4736-AF58-77E91D5B5E4CQ45185642-DFA746B4-028C-4F1E-B8EF-9CC6E70B1848Q45201742-89303276-6BCA-4FF2-ACCF-31F0B7EBDFCAQ45324780-E4BA182B-2AE8-4417-9428-3612D94BF3C4Q45352108-D04CED6D-6EC9-4686-9E70-68F30DD92035Q45352863-467C9923-C9B4-41FF-91F1-C05106C3B319
P2860
An ELISA for putative neutralizing antibodies to hepatitis E virus detects antibodies to genotypes 1, 2, 3, and 4.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
An ELISA for putative neutrali ...... s to genotypes 1, 2, 3, and 4.
@en
An ELISA for putative neutrali ...... s to genotypes 1, 2, 3, and 4.
@nl
type
label
An ELISA for putative neutrali ...... s to genotypes 1, 2, 3, and 4.
@en
An ELISA for putative neutrali ...... s to genotypes 1, 2, 3, and 4.
@nl
prefLabel
An ELISA for putative neutrali ...... s to genotypes 1, 2, 3, and 4.
@en
An ELISA for putative neutrali ...... s to genotypes 1, 2, 3, and 4.
@nl
P2093
P1433
P1476
An ELISA for putative neutrali ...... s to genotypes 1, 2, 3, and 4.
@en
P2093
Robert H Purcell
Suzanne U Emerson
Yi-Hua Zhou
P304
P356
10.1016/J.VACCINE.2003.12.017
P407
P577
2004-06-01T00:00:00Z